Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Journal Article
Number of items: 6.

Journal Article

Furlanetto, Jenny, Moebus, Volker, Schneeweiss, Andreas, Rhiem, Kerstin, Tesch, Hans, Blohmer, Jens-Uwe, Luebbe, Kristina, Untch, Michael, Salat, Christoph, Huober, Jens, Klare, Peter, Schmutzler, Rita, Couch, Fergus J., Lederer, Bianca, Gerber, Bernd, Zahm, Dirk-Michael, Bauerfeind, Ingo, Nekljudova, Valentina, Hanusch, Claus, Jackisch, Christian, Link, Theresa, Loibl, Sibylle and Fasching, Peter A. (2020). Germline (G)BRCA1/2 Mutations (M) and Hematological Toxicities in Patients (PTS) with Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemotherapy (NACT). Oncol. Res. Treat., 43. S. 22 - 23. BASEL: KARGER. ISSN 2296-5262

Furlanetto, Jenny, Moebus, Volker, Schneeweiss, Andreas, Rhiem, Kerstin, Tesch, Hans, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X, Luebbe, Kristina, Untch, Michael, Salat, Christoph, Huober, Jens, Klare, Peter, Schmutzler, Rita, Couch, Fergus J., Lederer, Bianca, Gerber, Bernd, Zahm, Dirk-Michael, Bauerfeind, Ingo, Nekljudova, Valentina, Hanusch, Claus, Jackisch, Christian, Link, Theresa, Hahnen, Eric, Loibl, Sibylle and Fasching, Peter A. (2021). Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy. Eur. J. Cancer, 145. S. 44 - 53. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Gerber, Bernd, Schneeweiss, Andreas, Moebus, Volker, Golatta, Michael ORCID: 0000-0002-2605-0060, Tesch, Hans, Krug, David ORCID: 0000-0001-8811-5416, Hanusch, Claus, Denkert, Carsten, Luebbe, Kristina, Heil, Joerg, Huober, Jens, Ataseven, Beyhan ORCID: 0000-0002-2823-7590, Klare, Peter, Hahn, Markus, Untch, Michael, Kast, Karin, Jackisch, Christian, Thomalla, Joerg, Seither, Fenja, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X, Rhiem, Kerstin, Fasching, Peter A., Nekljudova, Valentina, Loibl, Sibylle and Kuehn, Thorsten ORCID: 0000-0002-8708-2824 (2022). Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial. Cancers, 14 (3). BASEL: MDPI. ISSN 2072-6694

Schneeweiss, Andreas, Michel, Laura L., Moebus, Volker, Tesch, Hans, Klare, Peter, Hahnen, Eric, Denkert, Carsten, Kast, Karin, Pohl-Rescigno, Esther, Hanusch, Claus, Link, Theresa, Untch, Michael, Jackisch, Christian, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X, Fasching, Peter A., Solbach, Christine, Schmutzler, Rita K., Huober, Jens, Rhiem, Kerstin, Nekljudova, Valentina, Luebbe, Kristina and Loibl, Sibylle (2022). Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer. Eur. J. Cancer, 160. S. 100 - 112. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Schneeweiss, Andreas, Moebus, Volker, Tesch, Hans, Hanusch, Claus, Denkert, Carsten, Luebbe, Kristina, Huober, Jens, Klare, Peter, Kuemmel, Sherko, Untch, Michael, Kast, Karin, Jackisch, Christian, Thomalla, Joerg, Ingold-Heppner, Barbara, Blohmer, Jens-Uwe, Rezai, Mahdi, Frank, Matthias, Engels, Knut, Rhiem, Kerstin, Fasching, Peter Andreas, Nekljudova, Valentina, von Minckwitz, Gunter and Loibl, Sibylle (2019). Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial. Eur. J. Cancer, 106. S. 181 - 193. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Von Minckwitz, Gunter, Hahnen, Eric, Fasching, Peter A., Hauke, Jan, Schneeweiss, Andreas, Salat, Christoph, Rezai, Mandi, Blohmer, Jens U., Zahm, Dirk Michael, Jackisch, Christian, Gerber, Bernd, Klare, Peter, Kummel, Sherko, Eidtmann, Holger, Paepke, Stefan, Nekljudova, Valentina, Le Loibl, Sibyl, Untch, Michael and Schmutzler, Rita K. (2014). Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Wed Apr 24 00:56:31 2024 CEST.